Relief Therapeutics Holding AG (RLFTF)

[Whalatane]

Wilma ..I addressed some of your concerns in a previous post
But briefly.
We have just given half the US market to NeuroRx ..who were previously contract players for us ...contracted to run the US trials that we were paying for. . So thats a huge give and shows you how bad we need them to try and get this thru FDA approval. .

We don't know how well RLF-100 really works , who it works best on ...and how early to start putting patients on IV RLF-100...UNTIL we have the data from the properly powered double blinded placebo controlled trial we are currently running .

So we dont know if its really 90% effective based on the data we have so far ....the patient numbers are just too small to extrapolate that out to thousands of hospitalized Covid patients.

We need a time line for final enrollment of the IV trial.

Kiwi